Funding for this research was provided by:
National Institute on Drug Abuse (UG1DA040316-0S64)
Received: 17 March 2022
Accepted: 2 February 2023
First Online: 11 February 2023
: This study was approved by the HealthPartners Institutional Review Board (IRB), Study A20-156. All participants provided informed consent.
: Not applicable.
: The authors declare that they have no competing interests.